Definitive Contract HHSN261201000116C

Ended Awarded Last action

Contract number
HHSN261201000116C
Awardee
Awarding agency
Obligated
$198,751

Award facts

Contract value 100% obligated
$198,751.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 41 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Palo Alto, CA 94301, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $198,751

About this award

Written by GovTribe AI ·

This is a $198,751 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Genomic Systems, LLC. The contract is for research and development in the TAS::75 0849::TAS area and has a period of performance ending on September 30, 2011. This SBIR Phase I contract was awarded on a Firm Fixed Price basis.

Quick answers

Who was awarded contract HHSN261201000116C?

HHSN261201000116C was awarded to Genomic Systems, LLC by National Cancer Institute (National Institutes of Health) on September 30, 2010.

How much is contract HHSN261201000116C worth?

The government has obligated $198,751 on HHSN261201000116C.

Was contract HHSN261201000116C competed?

The extent of competition for HHSN261201000116C was full and open competition after exclusion of sources. The government received 41 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login